Endothelin receptors as novel targets in tumor therapy
<p>Abstract</p> <p>The endotelin (ET) axis, that includes ET-1, ET-2, ET-3, and the ET receptors, ET<sub>A </sub>and ET<sub>B</sub>, plays an important physiological role, as modulator of vasomotor tone, tissue differentiation and development, cell prolifera...
Main Authors: | Bagnato Anna, Natali Pier |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-05-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/2/1/16 |
Similar Items
-
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma
by: Anna Russignan, et al.
Published: (2021-01-01) -
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
by: Frederik C. Enevoldsen, et al.
Published: (2020-03-01) -
Targeting Endothelin-1 Receptor/β-Arrestin-1 Axis in Ovarian Cancer: From Basic Research to a Therapeutic Approach
by: Piera Tocci, et al.
Published: (2019-09-01) -
The contribution of endothelin-1 in colorectal cancer & the efficacy of the novel endothelin receptor antagonist ZD4054
by: Haque, S.
Published: (2014) -
YAP and endothelin-1 signaling: an emerging alliance in cancer
by: Piera Tocci, et al.
Published: (2021-01-01)